TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

NCT07246304 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer ( SCLC )
CAR-T Cell Therapy

Interventions

BIOLOGICAL: TC-D101 CAR-T

Sponsor

TCRCure Biopharma Ltd.

Collaborators

[object Object]